Key facts
- In July 2024, 24 countries reported measles data to The European Surveillance System (TESSy), with 815 cases reported by 18 countries. Six countries reported zero cases.
- Through its epidemic intelligence activities, ECDC has identified 2 026 new measles cases in 16 EU/EEA countries that were not reported before the last monthly update in August.
- In 2024, 19 measles-related deaths have been reported in Romania (18) and Ireland (1).
- Overall in the EU/EEA, over the last 12 months, there has been high measles activity; however, the situation varies by country. Some countries have reported large and/or ongoing outbreaks and others have reported sustained no or very low transmission.
- Relevant updates outside the EU/EEA are available for Switzerland, the United Kingdom (UK), countries in the Western Balkan, and WHO Regions.
Overview
In July 2024, 24 countries reported measles data to The European Surveillance System (TESSy), with 815 cases reported by 18 countries. Six countries reported zero cases.
In the most recent 12-month period, from 1 August 2023 to 31 July 2024, 30 EU/EEA Member States reported a total of 17 949 cases of measles, 13 871 (77.3%) of which were laboratory confirmed. During this 12-month period, two countries (Latvia and Liechtenstein) reported zero cases. The highest number of cases were reported by Romania (14 086), Italy (845), Belgium (576), Austria (523) and France (479). The highest notification rates were observed in infants under one year of age (579.1 cases per million) and children aged 1-4 years (342.4 cases per million). Thirteen deaths attributable to measles were reported to ECDC during the 12-month period by Romania (12) and Ireland (1). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases and the Measles and Rubella monthly report.
Complementary epidemic intelligence surveillance, with data collection conducted on 11 September 2024 from official public and media sources, detected 2 026 new suspected and/or confirmed measles cases that were not reported before the last monthly update in August. New cases were reported in 16 EU/EEA countries in recent months: Austria (new: 12; total: 502), Belgium (new: 255; total: 530), Denmark (new: 5, total: 25), Finland (new: 2, total: 2), France (new: 86; total: 386), Germany (new: 221; total: 620), Ireland (new: 24; total: 106, including 1 death), Italy (new: 2; total: 809), Luxembourg (new: 1, total: 1), Netherlands (new: 9; total: 156), Norway (new: 1; total: 10), Poland (new: 15; total: 261), Portugal (new: 1; total: 35), Romania (new: 1 382; total: 21 167, including 18 deaths), Slovakia (new: 4, total: 4), Sweden (new: 3; total: 26). Overall, 19 measles-related deaths have been reported in the EU/EEA in 2024, in Romania (18) and Ireland (1).
Relevant updates for outside the EU/EEA are available for Switzerland, the UK, and countries in the Western Balkan and WHO Regions.
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with epidemic intelligence updates since last month:
Austria reported 502 confirmed measles cases in 2024 as of 10 September 2024, an increase of 12 cases since 09 August 2024. Of the 489 cases for which hospitalisation information was available, 105 individuals (21%) were hospitalised, including four in the intensive care unit. All regions reported at least one case of measles in 2024, with most of the cases reported in Lower Austria (117, 23%) and Tyrol (88, 18%).
Belgium reported 530 confirmed measles cases in TESSy between January to August 2024 and as of 11 September 2024, an increase of 255 cases since 12 August 2024.
Denmark reported 25 cases in 2024 and as of 11 September 2024, an increase by five cases since the monthly update in August.
Finland reported two cases of measles in 2024 and as of 11 September 2024.
France reported 386 measles cases in TESSy between January and July 2024, an increase of 86 cases since the monthly report in August. Of these, 46 cases were reported in July.
Germany reported 620 confirmed and suspected measles cases in 2024 (data as of 11 September 2024), an increase of 221 cases since 8 August 2024.
Ireland has reported 106 confirmed measles cases as of 9 September 2024, an increase of 24 cases since the last monthly update on 9 August 2024. In addition, 25 cases are currently under investigation. Outbreaks have been reported across all six Health Service Executive (HSE) regions.
Italy reported 809 measles cases in TESSy between January and July 2024, two more than last month. Of these, 91 cases were reported in July.
Luxembourg reported one measles case in TESSy in July 2024.
Netherlands reported 156 cases of measles in 2024 and as of 21 August 2024, an increase of 9 cases since 24 July 2024.
Norway reported ten cases as of 11 September 2024, an increase of one since 12 August 2024.
Poland reported 261 measles cases from January to 31 August 2024, an increase of 15 cases since 31 July 2024.
Portugal has reported 35 confirmed measles cases from January to 3 September 2024, an increase of one case since 23 July 2024.
Romania has reported 21 167 cases, including 18 deaths, from January to 1 September 2024, an increase of 1 382 cases since 4 August 2024. This nationwide outbreak started in 2023, and 23 972 confirmed measles cases, including 21 deaths, have been reported from 1 January 2023 to 1 September 2024. The cases have been reported in all 41 counties and the Municipality of Bucharest. Among cases with known vaccination status (21 593), unvaccinated individuals across
all age groups accounted for 90%.
Slovakia reported four measles cases in 2024 and as of 10 September 2024.
Sweden has reported 26 cases in 2024 as of 11 September, an increase of three cases since of 8 August 2024. Recently, media reported of several imported measles cases, including in Stockholm.
Relevant epidemiological summary for countries outside the EU/EEA:
Switzerland reported 94 cases in 2024 and as of 2 September 2024, an increase of one case since 5 August 2024.
United Kingdom has reported several outbreaks of measles in 2024. As of 29 August, 2 387 measles cases have been confirmed in England in 2024, an increase of 109 cases since 22 July 2024. In Northern Ireland, 18 cases were confirmed between January and 1 September 2024. In Scotland there have been 17 laboratory-confirmed measles cases in 2024 and as of 4 September 2024. As of 31 July 2024, Wales confirmed 17 measles cases.
Western Balkans: Several countries continue to report measles cases.
Bosnia and Herzegovina
The Republic of Srpska has reported 308 measles cases as of 6 September 2024, an increase of 12 cases since 2 August 2024. As of 11 September 2024, the Federation of Bosnia and Herzegovina notified 7189 measles cases, including one death in 2024, an increase of 129 cases 3 August 2024. As of 8 August 2024, Brcko district reported 188 measles cases in 2024. This is an increase of 74 cases since May.
Serbia reported 348 measles cases as of 31 August 2024, an increase by 93 cases since 7 August.
Montenegro reported 25 measles cases as of 9 September 2024, an increase by 13 measles cases since 2 August, of which 22 (88%) were in unvaccinated individuals.
Summary for WHO regional offices
At the time of data collection (11 September 2021), the monthly measles cases report from the WHO covered a period up to and including July 2025 (data as of 5 August 2024).
A detailed breakdown was included in our last monthly report. As of 5 August 2024, the following numbers of measles cases were reported in each WHO region:
- WHO Regional Office for Europe (WHO/EUROPE): 84 932*
- WHO Regional Office for Africa (WHO AFRO): 58 551
- WHO Regional Office for the Americas (WHO PAHO): 282
- WHO Regional Office for the Eastern Mediterranean (WHO EMRO): 63 252
- WHO Regional Office for South-East Asia (WHO SEARO): 22 522
- WHO Regional Office for the Western Pacific (WHO WPRO): 8 033
*The numbers provided to WHO for EU/EEA countries are from TESSy data, updated monthly and available on ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting time the numbers may not correspond to the data from epidemic intelligence screening.
ECDC assessment
The overall number of measles cases in the EU/EEA has been steadily increasing since June 2023. Measles cases may continue increasing in the EU/EEA in the coming months. This is due to reported sub-optimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries (<95% in many of these countries), as well as a high probability of importation from areas experiencing high circulation. In addition, the majority of recently reported cases have acquired the disease within the reported country through community/local transmission, indicating a higher probability of being exposed to the virus within the EU/EEA than in previous months.
As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance, and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of sub-optimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with underserved populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies, to reduce inequalities in vaccine uptake.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response' published in February 2024 and the conclusions of that remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries. ECDC's latest advice on measles is available in the Threat Assessment Brief, 'Measles on the rise in the EU/EEA: Considerations for a public health response', published on 15 February 2024.